Publication: Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
| dc.contributor.author | Kissling, Esther | |
| dc.contributor.author | Rose, Angela Mc | |
| dc.contributor.author | Emborg, Hanne-Dorthe | |
| dc.contributor.author | Gherasim, Alin Manuel | |
| dc.contributor.author | Pebody, Richard | |
| dc.contributor.author | Pozo Sanchez, Francisco | |
| dc.contributor.author | Trebbien, Ramona | |
| dc.contributor.author | Mazagatos, Clara | |
| dc.contributor.author | Whitaker, Heather | |
| dc.contributor.author | Valenciano, Marta | |
| dc.contributor.author | European IVE group | |
| dc.contributor.author | Larrauri, Amparo | |
| dc.contributor.author | Casas Flecha, Inmaculada | |
| dc.contributor.author | Delgado-Sanz, Concepcion | |
| dc.contributor.author | Oliva Dominguez, Jesus Angel | |
| dc.date.accessioned | 2020-01-29T11:50:04Z | |
| dc.date.available | 2020-01-29T11:50:04Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates among all ages in primary care was 32-43% against influenza A; higher against A(H1N1)pdm09 and lower against A(H3N2). Among hospitalised older adults, VE estimates were 34-38% against influenza A and slightly lower against A(H1N1)pdm09. Influenza vaccination is of continued benefit during the ongoing 2018/19 influenza season. | es_ES |
| dc.description.peerreviewed | Sí | es_ES |
| dc.description.sponsorship | Funding: ECDC has contributed to fund some of the study sites and the coordination of the EU-PC study. WHO-EURO has contributed to fund the Romanian site in EU-PC and EU-H. Epiconcept has contributed to fund the EU-H study. | es_ES |
| dc.format.number | 8 | es_ES |
| dc.format.volume | 24 | es_ES |
| dc.identifier.citation | Euro Surveill. 2019 Feb;24(8):1900121. | es_ES |
| dc.identifier.doi | 10.2807/1560-7917.ES.2019.24.1900121 | es_ES |
| dc.identifier.e-issn | 1560-7917 | es_ES |
| dc.identifier.issn | 1560-7917 | es_ES |
| dc.identifier.journal | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | es_ES |
| dc.identifier.pubmedID | 30808440 | es_ES |
| dc.identifier.uri | http://hdl.handle.net/20.500.12105/8980 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | European Centre for Disease Prevention and Control (ECDC) | |
| dc.relation.publisherversion | https://doi.org/10.2807/1560-7917.ES.2019.24.1900121 | es_ES |
| dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
| dc.repisalud.centro | ISCIII::Centro Nacional de Epidemiología | es_ES |
| dc.repisalud.institucion | ISCIII | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.license | Atribución 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
| dc.subject | Europe | es_ES |
| dc.subject | Influenza | es_ES |
| dc.subject | Multicentre study | es_ES |
| dc.subject | Test-negative design | es_ES |
| dc.subject | Vaccination | es_ES |
| dc.subject | Vaccine effectiveness | es_ES |
| dc.subject | Vaccines and immunisation | es_ES |
| dc.title | Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019 | es_ES |
| dc.type | research article | es_ES |
| dc.type.hasVersion | VoR | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | e264f82c-6c07-4aa5-9f71-45e555f6592b | |
| relation.isAuthorOfPublication | 5611ffc3-de88-4908-b20a-9a15a58c060a | |
| relation.isAuthorOfPublication | e177bf8c-3734-480b-a2ae-4ae67491776c | |
| relation.isAuthorOfPublication | e77e1f2d-b4e2-4ba5-a853-c2795850dcae | |
| relation.isAuthorOfPublication | e2df6e55-f1d3-423b-a72f-fd9a69cf5915 | |
| relation.isAuthorOfPublication | e89a616b-8c7b-43b9-b3df-2a44c45e0765 | |
| relation.isAuthorOfPublication | e5273a7c-5f8e-464e-bea8-d933a72965b7 | |
| relation.isAuthorOfPublication.latestForDiscovery | e264f82c-6c07-4aa5-9f71-45e555f6592b | |
| relation.isPublisherOfPublication | 844b1441-479c-4219-87e5-efc493160a02 | |
| relation.isPublisherOfPublication.latestForDiscovery | 844b1441-479c-4219-87e5-efc493160a02 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Interim201819InfluenzaVaccine_2019.pdf
- Size:
- 562.72 KB
- Format:
- Adobe Portable Document Format
- Description:


